-
QIAGEN führt FFPE- und Flüssigbiopsie-PIK3CA-Diagnostika in Europa ein, um die Präzisionsmedizin bei fortgeschrittenem Brustkrebs zu verbessern https://www.pressebox.de?boxid=991107&source=twitter_globalpressebox.de/?boxid=991107& …
#Pik3ca#Hilden#QIAGENNV -
Associated with sporadic somatic activating mutations in PIK3CA, CLOVES is part of the
#PIK3CARelatedOvergrowthSpectrum (#PROS). Patients are at increased risk to develop Wilms tumor.#PIK3CA -AKT signaling pathway: https://www.ncbi.nlm.nih.gov/pubmed/25557259 pic.twitter.com/q6kSqShCT4
Prikaži ovu nit -
Nieuw! In deze nieuwe video vertellen Joni (11), Kylian (19) en Wilma (25) over hun PIK3ca-aandoeningen en deelt dr Maroeska te Loo (Hecovan, Radboudumc) de nieuwe medische ontwikkelingen zoals medicatie.
https://www.youtube.com/watch?v=6vKQ8UmYbVw …
@MaroeskaTeloo,@HecovanNijmegen#PIK3ca -
Brain tumours manipulate neighbouring synapses https://www.nature.com/articles/d41586-020-00137-x …
@nature#glia#braincancer#PIK3CA#PI3K https://www.nature.com/articles/s41586-020-1952-2 … => how#glioblastoma alters the neuronal microenvironment:#Glypican (GPC3) promotes tumorigenesispic.twitter.com/WKmH1bGAmu
-
Dr. B.
#Deneen's lab@bcmhouston et al discovered that#glioblastoma (#BrainTumor) modulates the activity of neighboring neurons in ways that promote tumor growth and also may trigger#seizures@nature#PIK3CA https://twitter.com/GENbio/status/1222883241683800064 …
-
Just released! New paper by Dr. B.
#Deneen et al in@nature shows that#BrainTumors remodel neuronal#synapses in ways that promote tumor growth and how they do it@bcmhouston#glioma#PIK3CA https://go.nature.com/38NH0ww pic.twitter.com/GB3PH0J6ah
-
Nieuw! Uitleganimatie over PIK3ca
https://www.youtube.com/watch?v=OcFt98u5NDU&t=11s …
Met dank aan dr Maroeska te Loo voor haar medewerking bij deze animatie (Hecovan, Radboudumc)
@MaroeskaTeloo,@HecovanNijmegen#vascularanomalies#PIK3ca pic.twitter.com/oHqhO0tWQj
-
-
And for those with a PIK3CA mutation, alpelisib provides new treatment options and hope
#SABCS19#oncoalert#bcsm#ERpos#PIK3CA pic.twitter.com/LvqgEGYCGP
-
@VasanNeil is presenting our work on double#PIK3CA mutations right now. Go bother him! @SABCSSanAntonio#SABCS19 @OncoAlert#medtwitter#breastcancer @sloan_ketteringpic.twitter.com/n0adMwBFSe
-
El Dr.Federico Rojo nos pone al día en los nuevos
#biomarcadores en cáncer de mama:#PDL1 (SP142) TILs en TNBC y#PIK3CA#CursoActualización2019pic.twitter.com/rCnoGGJ1xO
-
@curijoey: Towards new#prognosis- &#biomarker- driven#BRCA1#PD-L1 ##PTEN#PIK3Ca#LIV1#TROP2 classification & treatment of#TNBC#ABCLisbon@ESOncology@myESMOpic.twitter.com/s7kyjPvCPT
-
#NeoGenomics glad to see full crowd at#PIK3CA talk now at#AMPath19.pic.twitter.com/GnRzK2Q6Qe
-
#OncoAlert Dual (in cis)#PIK3CA mutations in#bcsmhttps://twitter.com/ScaltritiLab/status/1192531908082749445 … -
Here is our new work in
#sciencemagazine. The presence of double (in cis)#PIK3CA mutations in#breastcancer hyperactivate (further) the#PI3K pathway and sensitize to PI3Kα inhibitors. https://bit.ly/2NJ15Lm@sloan_kettering@WeillCornell@Columbia@IcahnMountSinaiPrikaži ovu nit -
Interesting talks on the challenges of studying
#PIK3CA-related overgrowth syndrome (PROS) by@rksemple and@pierrevabres at the fantastic 2nd London International Mosaicism Symposium organised by Veronica Kinsler@KinslerLab#MosaicismLondonpic.twitter.com/Q6sod3jecy
-
Many thanks to those of you who were cheerleaders
for us, who read and re-read, who critiqued, advised and who collaborated!!! We are truly grateful for your support
#KeepingEverythingCrossed#ChanZuckerbergInitiative#PatientLedResearchNetwork#ClovesSyndrome#PIK3CA pic.twitter.com/gXTI4YsUbn
-
-
It’s official! I’m getting 3 months of PIQRAY free, thanks to the
@Novartis Patient Assistance Fund. Thank you to@METUPorg,@Stickit2Stage4@AMJohnston1315 everyone that prayed, shared Tweets, etc.#piqray#apelisib#pik3ca#mbc#stayeIVneedsmorepic.twitter.com/rNwVycqk0C
-
Thanks 2 advocacy efforts by an amazing CLOVES family & our push to make noise about a new off label treatment option, I was invited to present at the FDA today about repurposing oncology meds. Grateful for this opportunity!
#PIK3CA#DesignCollaborateCure#CLOVESSyndromepic.twitter.com/w495NAKniW
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Food for thought...my tumor marker is down 11 points on my latest bloodwork after only 10 days of